Tremor epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 12: Line 12:
===Prevalence===
===Prevalence===
*The [[prevalence]] of [[essential tremor]] is approximately 0.4% to 5.6%<ref name="pmid2885784">{{cite journal| author=Findley LJ, Koller WC| title=Essential tremor: a review. | journal=Neurology | year= 1987 | volume= 37 | issue= 7 | pages= 1194-7 | pmid=2885784 | doi=10.1212/wnl.37.7.1194 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2885784  }} </ref>.
*The [[prevalence]] of [[essential tremor]] is approximately 0.4% to 5.6%<ref name="pmid2885784">{{cite journal| author=Findley LJ, Koller WC| title=Essential tremor: a review. | journal=Neurology | year= 1987 | volume= 37 | issue= 7 | pages= 1194-7 | pmid=2885784 | doi=10.1212/wnl.37.7.1194 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2885784  }} </ref>.
*Seven million people worldwide and one million people in the United States are suffering from [[Parkinson's disease]].
*Seven million people worldwide and one million people in the United States are suffering from [[Parkinson's disease]].
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually.


===Case-fatality rate/Mortality rate===
===Case-fatality rate/Mortality rate===

Revision as of 17:28, 24 January 2021

Tremor Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tremor from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tremor epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tremor epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tremor epidemiology and demographics

CDC on Tremor epidemiology and demographics

Tremor epidemiology and demographics in the news

Blogs on Tremor epidemiology and demographics

Directions to Hospitals Treating Tremor

Risk calculators and risk factors for Tremor epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Zehra Malik, M.B.B.S[2]

Overview

Epidemiology and Demographics

Incidence

Prevalence

Case-fatality rate/Mortality rate

  • In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
  • The case-fatality rate/mortality rate of [disease name] is approximately [number range].

Age

Race

Gender

  • [Disease name] affects men and women equally.
  • Males are more commonly affected by Parkinson's disease than [female]. The [male] to [female] ratio is approximately 3:2[5].

Region

Developed Countries

Developing Countries

References

  1. de Lau LM, Breteler MM (2006). "Epidemiology of Parkinson's disease". Lancet Neurol. 5 (6): 525–35. doi:10.1016/S1474-4422(06)70471-9. PMID 16713924.
  2. Findley LJ, Koller WC (1987). "Essential tremor: a review". Neurology. 37 (7): 1194–7. doi:10.1212/wnl.37.7.1194. PMID 2885784.
  3. Samii A, Nutt JG, Ransom BR (2004). "Parkinson's disease". Lancet. 363 (9423): 1783–93. doi:10.1016/S0140-6736(04)16305-8. PMID 15172778.
  4. 4.0 4.1 Schoenberg BS (1987). "Descriptive epidemiology of Parkinson's disease: disease distribution and hypothesis formulation". Adv Neurol. 45: 277–83. PMID 3493626.
  5. Kalia LV, Lang AE (2015). "Parkinson's disease". Lancet. 386 (9996): 896–912. doi:10.1016/S0140-6736(14)61393-3. PMID 25904081.

Template:WH Template:WS